Clinical Trial Update: Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating safety and effectiveness of cyclosporin for managing COVID-19 acute respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Acute Respiratory Distress Syndrome
• Cytokine Release Syndrome
• Pulmonary Fibrosis

Drugs mentioned

• Cyclosporin (cyclosporine)

Snippet

Sponsor: Alexandria University | Conditions: COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome | Phase 3 | Status: COMPLETED